Analytical similarity assessment of rituximab biosimilar CT-P10 to reference medicinal product

CT-P10 (Truxima™) was recently approved as the world's first rituximab biosimilar product in the European Union (EU) and South Korea. To demonstrate biosimilarity of CT-P10 with the reference medicinal product (RMP), extensive 3-way similarity assessment has been conducted between CT-P10, EU-Ri...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:MAbs
Main Authors: Lee, Kyoung Hoon, Lee, Jihun, Bae, Jin Soo, Kim, Yeon Jung, Kang, Hyun Ah, Kim, Sung Hwan, Lee, So Jung, Lim, Ki Jung, Lee, Jung Woo, Jung, Soon Kwan, Chang, Shin Jae
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2018
Assuntos:
Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5916562/
https://ncbi.nlm.nih.gov/pubmed/29469653
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19420862.2018.1433976
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados